| Patent | Date |
|---|
Diprovocims: a new and potent class of TLR agonists
Grant 11,040,959 - Beutler , et al. June 22, 2 | 2021-06-22 |
Diprovocims: A New And Potent Class Of Tlr Agonists
App 20200207742 - Beutler; Bruce ; et al. | 2020-07-02 |
Peripheral Modifications On Pocket-redesigned Vancomycin Analogs Synergistically Improve Antimicrobial Potency And Durability
App 20200071359 - Boger; Dale L. | 2020-03-05 |
N-(hydrophobe-substituted) vancosaminyl [.PSI.-[C(=NH) NH] Tpg.sup.4] vancomycin and [.PSI.-[CH.sub.2NH]Tpg.sup.4] vancomycin
Grant 10,577,395 - Boger | 2020-03-03 |
Seco-cyclopropapyrroloindole compounds, antibody-drug conjugates thereof, and methods of making and use
Grant 10,287,291 - Yang , et al. | 2019-05-14 |
Pyrazole compounds and methods of making and using same
Grant 10,093,630 - Boger , et al. October 9, 2 | 2018-10-09 |
Seco-cyclopropapyrroloindole Compounds, Antibody-drug Conjugates Thereof, And Methods Of Making And Use
App 20180051031 - YANG; Fukang ; et al. | 2018-02-22 |
Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains
Grant 9,879,049 - Boger January 30, 2 | 2018-01-30 |
Tlr-independent Small Molecule Adjuvants
App 20170224653 - Boger; Dale L. ; et al. | 2017-08-10 |
Pyrazole Compounds And Methods Of Making And Using Same
App 20170190669 - BOGER; Dale L. ; et al. | 2017-07-06 |
N- (hydrophobe-substituted) Vancosaminyl [psi-[c(=nh) Nh] Tpg4] Vancomycin And [psi-[ch2nh]tpg4] Vancomycin
App 20170152291 - BOGER; Dale L. | 2017-06-01 |
Neoseptins: small molecule adjuvants
Grant 9,649,373 - Beutler , et al. May 16, 2 | 2017-05-16 |
Cyclic N-acyl O-amino phenol CBI derivative
Grant 9,586,974 - Boger March 7, 2 | 2017-03-07 |
Alpha-ketoheterocycles and methods of making and using
Grant 9,504,675 - Boger November 29, 2 | 2016-11-29 |
Glycopeptide Antibiotic Analogs Effective Against Vancomycin-resistant Bacterial Strains
App 20160272682 - Boger; Dale L. | 2016-09-22 |
Cyclic N-Acyl O-Amino Phenol CBI Derivative
App 20160016972 - Boger; Dale L. | 2016-01-21 |
Neoseptins: Small Molecule Adjuvants
App 20160000907 - BEUTLER; Bruce ; et al. | 2016-01-07 |
Cyclic prodrugs of duocarmycin analogs
Grant 9,139,596 - Boger September 22, 2 | 2015-09-22 |
Alpha-keto heterocycles as FAAH inhibitors
Grant 8,987,312 - Boger March 24, 2 | 2015-03-24 |
Cyclic Prodrugs Of Duocarmycin Analogs
App 20150057270 - Boger; Dale L. | 2015-02-26 |
10'-fluorinated Vinca alkaloids provide enhanced biological activity against MDR cancer cells
Grant 8,940,754 - Boger January 27, 2 | 2015-01-27 |
Tetracyclic Inhibitors Of Fatty Acid Amide Hydrolase
App 20140045800 - Boger; Dale L. | 2014-02-13 |
Alpha-ketoheterocycles And Methods Of Making And Using
App 20130338196 - Boger; Dale L. | 2013-12-19 |
Tetracyclic inhibitors of fatty acid amide hydrolase
Grant 8,372,823 - Boger February 12, 2 | 2013-02-12 |
10'-fluorinated Vinca Alkaloids Provide Enhanced Biological Activity Against Mdr Cancer Cells
App 20120329822 - Boger; Dale L. | 2012-12-27 |
C4-substituted Alpha-keto Oxazoles
App 20120302607 - Boger; Dale L. | 2012-11-29 |
Substituted oxazole ketone modulators of fatty acid amide hydrolase
Grant 8,268,817 - Boger September 18, 2 | 2012-09-18 |
Tricyclic inhibitors of fatty acid amide hydrolase
Grant 8,124,778 - Boger February 28, 2 | 2012-02-28 |
Alpha-keto Heterocycles As Faah Inhibitors
App 20110183947 - Boger; Dale L. | 2011-07-28 |
C4-substituted Alpha-keto Oxazoles
App 20110184026 - Boger; Dale L. | 2011-07-28 |
Oxazole ketones as modulators of fatty acid amide hydrolase
Grant 7,915,270 - Boger March 29, 2 | 2011-03-29 |
Tetracyclic Inhibitors Of Fatty Acid Amide Hydrolase
App 20100249078 - Boger; Dale L. | 2010-09-30 |
Tricyclic Inhibitors Of Fatty Acid Amide Hydrolase
App 20100216750 - Boger; Dale L. | 2010-08-26 |
Substituted oxazole ketone modulators of fatty acid amide hydrolase
App 20100075931 - Boger; Dale L. | 2010-03-25 |
Inhibitors of fatty acid amide hydrolase
Grant 7,662,971 - Boger February 16, 2 | 2010-02-16 |
Inhibitors Of Fatty Acid Amide Hydrolase
App 20090270421 - Boger; Dale L. | 2009-10-29 |
Inhibitors of fatty acid amide hydrolase
Grant 7,560,570 - Boger July 14, 2 | 2009-07-14 |
Compositions and Methods for Delivery of Antitumor Agents
App 20080267981 - Janda; Kim D. ; et al. | 2008-10-30 |
Methods for inhibiting angiogenesis and tumor growth
Grant 7,368,478 - Boger , et al. May 6, 2 | 2008-05-06 |
Oxadiazole ketone inhibitors of fatty acid amide hydrolase
App 20080096931 - Boger; Dale L. | 2008-04-24 |
Oxadiazole ketone inhibitors of fatty acid amide hydrolase
Grant 7,351,724 - Boger April 1, 2 | 2008-04-01 |
Oxazole ketones as modulators of fatty acid amide hydrolase
App 20070203156 - Boger; Dale L. | 2007-08-30 |
Ningalin B analogs employable for reversing multidrug resistance
Grant 7,250,409 - Boger July 31, 2 | 2007-07-31 |
[PSI[CH2NH]PG4] glycopeptide antibiotic analogs
App 20070173438 - Boger; Dale L. | 2007-07-26 |
Methods for inhibiting angiogenesis and tumor growth
Grant 7,115,660 - Boger , et al. October 3, 2 | 2006-10-03 |
Methods for inhibiting angiogenesis and tumor growth
App 20060211769 - Boger; Dale L. ; et al. | 2006-09-21 |
Oxadiazole ketone inhibitors of fatty acid amide hydrolase
App 20060100212 - Boger; Dale L. | 2006-05-11 |
Inhibitors of fatty acid amide hydrolase
App 20050239785 - Boger, Dale L. | 2005-10-27 |
Inhibitors of fatty acid amide hydrolase
Grant 6,891,043 - Boger May 10, 2 | 2005-05-10 |
Selective potentiation of serotonin receptor subtypes
Grant 6,858,649 - Boger February 22, 2 | 2005-02-22 |
CBI analogs of CC-1065 and the duocarmycins
App 20050032860 - Boger, Dale L. | 2005-02-10 |
CBI analogues of the duocarmycins and CC-1065
App 20050026987 - Boger, Dale L. | 2005-02-03 |
Cbi analogues of cc-1065 and the duocarmycins
App 20050014700 - Boger, Dale L. | 2005-01-20 |
Inhibition of angiogenesis and tumor growth
Grant 6,803,383 - Boger , et al. October 12, 2 | 2004-10-12 |
Serotonin potentiation by oleamide analogs
Grant 6,734,204 - Boger May 11, 2 | 2004-05-11 |
Analogues of thiocoraline and be-22179
App 20040072738 - Boger, Dale L | 2004-04-15 |
CBI analogs of CC-1065 and the duocarmycins
App 20040002528 - Boger, Dale L. | 2004-01-01 |
Ningalin b analogs employable for reversing multidrug resistance
App 20030220320 - Boger, Dale L | 2003-11-27 |
Convergent synthesis of combinatorial library
Grant 6,653,087 - Boger November 25, 2 | 2003-11-25 |
Method for screening DNA binding
App 20030165837 - Boger, Dale L. | 2003-09-04 |
Inhibitors of fatty acid amide hydrolase
App 20030092734 - Boger, Dale L. | 2003-05-15 |
Inhibition of angiognenesis and tumor growth
App 20030083519 - Boger, Dale L. ; et al. | 2003-05-01 |
Methods for inhibiting angiogenesis and tumor growth
App 20030078296 - Boger, Dale L. ; et al. | 2003-04-24 |
CBI analogs of CC-1065 and the duocarmycins
Grant 6,548,530 - Boger April 15, 2 | 2003-04-15 |
iso-CBI and iso-CI analogs of CC-1065 duocarmycins
Grant 6,486,326 - Boger November 26, 2 | 2002-11-26 |
Inhibitors of fatty acid amide hydrolase
Grant 6,462,054 - Boger October 8, 2 | 2002-10-08 |
Synthesis of CC-1065/duocarmycin analogs
App 20020082424 - Boger, Dale L. | 2002-06-27 |
iso-CBI and iso-CI analogs of CC-1065 duocarmycins
App 20020049335 - Boger, Dale L. | 2002-04-25 |
Sandramycin analogs
Grant 6,329,497 - Boger December 11, 2 | 2001-12-11 |
Synthesis of CC-1065/duocarmycin analogs
Grant 6,310,209 - Boger October 30, 2 | 2001-10-30 |
Analogs of duocarmycin and cc-1065
Grant 6,281,354 - Boger August 28, 2 | 2001-08-28 |
ISO-CBI and ISO-CI analogs of CC-1065 and the duocarmycins
Grant 6,262,271 - Boger July 17, 2 | 2001-07-17 |
Inhibitors of gap junction communication
Grant 6,251,931 - Boger , et al. June 26, 2 | 2001-06-26 |
Template for solution phase synthesis of combination libraries
Grant 6,194,612 - Boger , et al. February 27, 2 | 2001-02-27 |
Inhibitors of oleamide hydrolase
Grant 6,096,784 - Lerner , et al. August 1, 2 | 2000-08-01 |
Analogs of CC-1065 and the duocarmycins
Grant 6,060,608 - Boger May 9, 2 | 2000-05-09 |
MCBI analogs of CC-1065 and the duocarmycins
Grant 5,985,908 - Boger November 16, 1 | 1999-11-16 |
Process for antibody combining site-catalyzed SYN elimination in the formation of a CIS olefin
Grant 5,478,728 - Cravatt , et al. December 26, 1 | 1995-12-26 |
| 